Zurück geht es hier Grüezi! Sie wurden auf finanzen.ch, unser Portal für Schweizer Anleger, weitergeleitet.  Zurück geht es hier.

GEA Aktie 360133 / DE0006602006

06.11.2025 07:30:15

EQS-News: GEA accelerates third-quarter order intake and revenue growth, increases profitability

EQS-News: GEA Group Aktiengesellschaft / Key word(s): 9 Month figures/Quarter Results
GEA accelerates third-quarter order intake and revenue growth, increases profitability

06.11.2025 / 07:30 CET/CEST
The issuer is solely responsible for the content of this announcement.


Corporate press release GEA accelerates third-quarter order intake and revenue growth, increases profitability
  • Order intake increased by 5.5 percent to EUR 1,372 million (Q3 2024: EUR 1,301 million); organic growth of 8.4 percent
  • Revenue up by 1.2 percent to EUR 1,366 million in the third quarter (Q3 2024: EUR 1,350 million); organic growth of 4.5 percent
  • EBITDA before restructuring expenses further increased by 6.7 percent to EUR 232 million (Q3 2024: EUR 217 million); EBITDA margin before restructuring expenses up from 16.1 percent in prior-year quarter to 17.0 percent
  • Return on capital employed (ROCE) again improved to 35.4 percent (Q3 2024: 32.3 percent)
  • Net working capital, at 8.6 percent of revenue, within target range of 7.0 to 9.0 percent (Q3 2024: 9.3 percent)
  • Guidance for 2025 confirmed

Duesseldorf (Germany), November 6, 2025 – GEA continued its profitable growth trajectory in the third quarter of 2025 and once again improved key financial figures. Order intake and EBITDA before restructuring expenses increased markedly.
“Once again, our third quarter was very successful. Especially order intake showed visible growth across all order volumes. This is testament to our strong business model. Our performance was bolstered by further increases in profitability and revenue,” said GEA CEO Stefan Klebert. “In addition, GEA successfully entered the Dax via the demanding ‘Fast Entry’ procedure.”

Sustained order intake and revenue growth
Order intake in the third quarter of 2025 rose by 5.5 percent to EUR 1,372 million (Q3 2024: EUR 1,301 million). Organically, it grew by 8.4 percent. All order volumes contributed to this increase, including three large orders. Demand growth was particularly strong in the customer industries pharma, dairy farming and food.

The large order for Qatari milk and food producer Baladna Q.P.S.C., received in July this year, was not yet booked in the third quarter, but rather recorded in October of the current quarter, following receipt of the advance payment in the double-digit millions. The contract to build the world’s largest integrated dairy farm and milk powder facility in Algeria was awarded to GEA in the past quarter.

New machine and service business record organic revenue growth
Revenue increased slightly in the reporting quarter, rising by 1.2 percent to EUR 1,366 million (Q3 2024: EUR 1,350 million), with organic growth of 4.5 percent. Negative currency translation effects amounted to EUR 37 million (Q3 2024: EUR 19 million). Organic growth reached 2.7 percent in the new machine business and 7.3 percent in the particularly profitable service business. With higher total revenue, the share of the service business grew by 0.9 percentage points to 40.1 percent.
Higher gross profit continues to drive profitability
EBITDA before restructuring expenses rose by a further 6.7 percent to EUR 232 million in the third quarter (Q3 2024: EUR 217 million). The respective EBITDA margin again showed a substantial increase, up by 0.9 percentage points from 16.1 percent in the prior-year quarter to 17.0 percent. Net profit for the period rose by 7.8 percent to EUR 120.8 million (Q3 2024: EUR 112.0 million). Earnings per share before restructuring expenses went up from EUR 0.72 to EUR 0.76, while the earnings per share of EUR 0.74 also exceeded the prior-year figure of EUR 0.67.

Liquidity and profitability ratios remain positive
As of the September 30, 2025 reporting date, net debt amounted to EUR 36.3 million (September 30, 2024: net liquidity of EUR 65.9 million). This is solely attributable to the payments made for the share buyback program completed in April this year. Net working capital as a share of revenue improved to 8.6 percent, squarely within the target range of 7.0 to 9.0 percent (September 30, 2024: 9.3 percent). Return on capital employed (ROCE) rose to 35.4 percent (Q3 2024: 32.3 percent), primarily due to higher EBIT before restructuring expenses in the last twelve months.

The first nine months at a glance
Order intake in the first nine months of 2025 rose by 3.6 percent to EUR 4,096 million (9M 2024: EUR 3,955 million). This corresponds to 5.6 percent organic growth. Revenue rose slightly by 0.6 percent to EUR 3,936 million (9M 2024: EUR 3,914 million). Organically, revenue grew by 2.3 percent. EBITDA before restructuring expenses increased by 8.1 percent to EUR 646.7 million (9M 2024: EUR 598.2 million). The corresponding margin improved by 1.1 percentage points to 16.4 percent (9M 2024: 15.3 percent). At EUR 322.2 million, profit for the period in the first three quarters of 2025 was up 6.9 percent on the prior-year period (9M 2024: EUR 301.3 million). Earnings per share before restructuring expenses increased from EUR 1.97 to EUR 2.08. Earnings per share rose to EUR 1.97 (9M 2024: EUR 1.79).

Guidance for full year 2025 confirmed
GEA anticipates organic revenue growth between 2.0 and 4.0 percent for the financial year. The company expects an EBITDA margin before restructuring expenses between 16.2 and 16.4 percent and forecasts ROCE of 34 to 38 percent. The original guidance was increased on July 31 of this year.

Key Figures of GEA
(EUR million) Q3
2025
Q3
2024
Change
in %
Q1-Q3
2025
Q1-Q3
2024
Change
in %
Results of operations            
Order intake 1,372.4 1,300.6 5.5 4,096.4 3,955.0 3.6
Book-to-bill ratio 1.00 0.96 1.04 1.01
Order backlog 3,102.3 3,014.2 2.9 3,102.3 3,014.2 2.9
Revenue 1,365.9 1,349.8 1.2 3,936.2 3,914.4 0.6
Organic revenue growth1 4.5 1.4 314 bp 2.3 1.9 43 bp
Share of service revenue in % 40.1 39.2 95 bp 40.6 38.7 190 bp
EBITDA before restructuring expenses 231.7 217.1 6.7 646.7 598.2 8.1
as % of revenue 17.0 16.1 88 bp 16.4 15.3 115 bp
EBITDA 226.9 209.2 8.4 625.7 567.4 10.3
EBITA before restructuring expenses 193.4 181.1 6.8 536.0 491.3 9.1
EBITA 188.6 173.2 8.9 515.0 458.1 12.4
EBIT before restructuring expenses 179.7 168.3 6.8 492.3 452.3 8.9
EBIT 174.2 157.6 10.5 468.6 415.6 12.8
Profit for the period 120.8 112.0 7.8 322.2 301.3 6.9
ROCE in % 35.4 32.3 307 bp 35.4 32.3 307 bp
Financial position            
Cash flow from operating activities 119.6 180.3 -33.6 184.3 255.4 -27.8
Cash flow from investing activities -67.5 -54.2 -24.4 -142.9 -103.6 -38.0
Free cash flow 52.2 126.0 -58.6 41.4 151.8 -72.7
Net assets            
Net working capital (reporting date) 466.1 493.5 -5.6 466.1 493.5 -5.6
as % of revenue (LTM) 8.6 9.3 -71 bp 8.6 9.3 -71 bp
Capital employed (reporting date) 2,033.7 1,909.3 6.5 2,033.7 1,909.3 6.5
Equity 2,347.1 2,336.2 0.5 2,347.1 2,336.2 0.5
Equity ratio in % 41.1 41.0 11 bp 41.1 41.0 11 bp
Net liquidity (+)/Net debt (-)2 -36.3 65.9 -36.3 65.9
GEA Shares            
Earnings per share (EUR) 0.74 0.67 10.3 1.97 1.79 10.2
Earnings per share before restructuring expenses (EUR) 0.76 0.72 5.9 2.08 1.97 5.6
Market capitalization (EUR billion; reporting date)3 10.2 7.6 35.1 10.2 7.6 35.1
Employees (FTE; reporting date) 18,426 18,484 -0.3 18,426 18,484 -0.3
Total workforce (FTE; reporting date) 19,318 19,303 0.1 19,318 19,303 0.1
1) Adjusted for portfolio and currency translation effects.
2) Including lease liabilities of EUR 217.4 million as of September 30, 2025 (September 30, 2024: EUR 187.6 million).
3) XETRA closing price as of September 30, 2025: EUR 62.85; XETRA closing price as of September 30, 2024: EUR 43.96; In previous year the market capitalization still included treasury shares.

 
NOTES TO THE EDITOR
Contact Media Relations
Matthias Schnettler
Vice President Media Relations
Mobile: +49 (0) 162 34 63 734
Phone: +49 (0) 211 91 36 15 00
matthias.schnettler@gea.com

About GEA
GEA is one of the world’s largest suppliers of systems and components to the food, beverage and pharmaceutical industries. The international technology group, founded in 1881, focuses on machinery and plants, as well as advanced process technology, components and comprehensive services. For instance, every second pharma separator for essential healthcare products such as vaccines or novel biopharmaceuticals is produced by GEA. In food, every fourth package of pasta or every third chicken nugget are processed with GEA technology.
With more than 18,000 employees, the group generated revenues of about EUR 5.5 billion in more than 150 countries in the 2024 fiscal year. GEA plants, processes, components and services enhance the efficiency and sustainability of customers’ production. They contribute significantly to the reduction of CO2 emissions, plastic usage and food waste. In doing so, GEA makes a key contribution toward a sustainable future, in line with the company’s purpose: ”Engineering for a better world.”
GEA is listed on the DAX, the STOXX® Europe 600 Index and is also a constituent of the leading sustainability indices DAX 50 ESG, MSCI Global Sustainability and Dow Jones Best-in-Class World.
More information can be found online at www.gea.com.

If you do not want to receive any further information from GEA, please send an e-mail to pr@gea.com.
 


06.11.2025 CET/CEST Dissemination of a Corporate News, transmitted by EQS News - a service of EQS Group.
The issuer is solely responsible for the content of this announcement.

The EQS Distribution Services include Regulatory Announcements, Financial/Corporate News and Press Releases.
View original content: EQS News


Language: English
Company: GEA Group Aktiengesellschaft
Ulmenstrasse 99
40476 Düsseldorf
Germany
Phone: +49 (0)211 9136-0
E-mail: ir@gea.com
Internet: www.gea.com
ISIN: DE0006602006
WKN: 660200
Indices: DAX
Listed: Regulated Market in Berlin, Dusseldorf, Frankfurt (Prime Standard), Hamburg, Munich; Regulated Unofficial Market in Hanover, Stuttgart, Tradegate Exchange
EQS News ID: 2224616

 
End of News EQS News Service

2224616  06.11.2025 CET/CEST

Analysen zu GEA

  • Alle
  • Kaufen
  • Hold
  • Verkaufen
  • ?
07:04 GEA Sector Perform RBC Capital Markets
07.11.25 GEA Underweight JP Morgan Chase & Co.
07.11.25 GEA Halten DZ BANK
07.11.25 GEA Hold Deutsche Bank AG
06.11.25 GEA Buy UBS AG
Eintrag hinzufügen

Erfolgreich hinzugefügt!. Zu Portfolio/Watchlist wechseln.

Es ist ein Fehler aufgetreten!

Kein Portfolio vorhanden. Bitte zusätzlich den Namen des neuen Portfolios angeben. Keine Watchlisten vorhanden. Bitte zusätzlich den Namen der neuen Watchlist angeben.

CHF
Hinzufügen

Mittwoch um 18 Uhr live: Die Illusion der Erinnerung - Wie du Denkfehler im Trading vermeidest

Erfahrung ist wertvoll - doch Erinnerungen sind trügerisch. Sie verzerren, ergänzen oder lassen Details weg, bis ein falsches Bild entsteht. Dieses Webinar zeigt, warum das Gehirn keine objektive Aufzeichnung liefert und wie diese Verzerrungen Trading-Entscheidungen unbewusst beeinflussen.

Schnell noch Plätze sichern!

Abnehmspritzen – Ist der Hype vorbei? – mit Tim Schäfer

Ist der Hype um Abnehmspritzen wie bei Novo Nordisk und Eli Lilly vorbei – oder stehen wir erst am Anfang einer langfristigen Revolution im Gesundheitswesen? 💉📉

Im heutigen Gespräch mit Tim Schäfer @TimSchaeferMedia sprechen wir über die spannendsten Pharmawerte 2025. Neben den Abnehmspritzen blicken wir auch auf klassische Pharma-Giganten wie Pfizer, Johnson & Johnson, Roche, Novartis, AstraZeneca und GSK. Tim analysiert Übertreibungen, Rücksetzer und langfristige Chancen für Buy-and-Hold-Strategien – mit Fokus auf Dividende, KGV und Krisenresistenz.

💬 Was ist vom Abnehmtrend langfristig zu halten?
💬 Welche Pharma-Aktien sind aktuell unterbewertet?
💬 Was spricht für konservative Dividendenwerte im Gesundheitssektor?

👉🏽 https://bxplus.ch/wall-street-live-mit-tim-schaefer/

Abnehmspritzen – Ist der Hype vorbei? – Wall Street Live mit Tim Schäfer

Mini-Futures auf SMI

Typ Stop-Loss Hebel Symbol
Short 12’974.31 19.37 BP9SUU
Short 13’215.46 13.98 BU9S6U
Short 13’724.19 8.85 B19SNU
SMI-Kurs: 12’465.39 10.11.2025 17:30:00
Long 11’962.62 19.84 SNLBQU
Long 11’690.01 13.82 SSTBSU
Long 11’209.46 8.98 SQZB6U
Die Produktdokumentation, d.h. der Prospekt und das Basisinformationsblatt (BIB), sowie Informationen zu Chancen und Risiken, finden Sie unter: https://keyinvest-ch.ubs.com

Aktien in diesem Artikel

GEA 56.30 0.34% GEA